REDUCTION IN NON-ELECTIVE RESPIRATORY-RELATED HOSPITALIZATIONS IN PATIENTS TREATED WITH PIRFENIDONE: POOLED ANALYSES FROM THREE PHASE 3 TRIALS OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS

Ley B.; Swigris J. J.; Day B.; Stauffer J.; Chou W.; Raimundo K.; Collard H.

首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >REDUCTION IN NON-ELECTIVE RESPIRATORY-RELATED HOSPITALIZATIONS IN PATIENTS TREATED WITH PIRFENIDONE: POOLED ANALYSES FROM THREE PHASE 3 TRIALS OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS

【24h】

REDUCTION IN NON-ELECTIVE RESPIRATORY-RELATED HOSPITALIZATIONS IN PATIENTS TREATED WITH PIRFENIDONE: POOLED ANALYSES FROM THREE PHASE 3 TRIALS OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS

机译：吡非尼酮治疗的患者的非电子呼吸相关的住院治疗的减少：哌立尼酮的3期3次试验在特发性肺纤维化中的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thorax: The Journal of the British Thoracic Society》 |2016年第3期|共4页
作者
Ley B.; Swigris J. J.; Day B.; Stauffer J.; Chou W.; Raimundo K.; Collard H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. REDUCTION IN NON-ELECTIVE RESPIRATORY-RELATED HOSPITALIZATIONS IN PATIENTS TREATED WITH PIRFENIDONE: POOLED ANALYSES FROM THREE PHASE 3 TRIALS OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS [J] . Ley B., Swigris J. J., Day B., Thorax: The Journal of the British Thoracic Society . 2016,第Suppla3期

机译：吡非尼酮治疗的患者的非电子呼吸相关的住院治疗的减少：哌立尼酮的3期3次试验在特发性肺纤维化中的分析
2. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials [J] . Carlo Albera, Carlos A. Pereira, David J. Lederer, The European respiratory journal : . 2016,第1期

机译：吡非尼酮用于特发性肺纤维化：来自三项跨国3期试验的合并数据分析
3. ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES [J] . Noble P. W., Albera C., Chou W., Thorax: The Journal of the British Thoracic Society . 2016,第Suppla3期

机译：吡非尼酮治疗的特发性肺纤维化患者亚组中FVC的年率下降：3项重要研究的结果分析
4. Acoustic evaluation of pirfenidone on patients with combined pulmonary fibrosis emphysema syndrome [C] . Sonia Charleston-Villalobos, Norma Castañeda-Villa, Ramón Gonzàlez-Camarena, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：吡非尼酮对合并肺纤维化性肺气肿综合征的声学评价
5. Correlation of Vascular Leak Measured Using Gadofosveset-Enhanced Lung Magnetic Resonance Imaging with Radiographic and Physiologic Measures of Fibrosis in Patients with Idiopathic Pulmonary Fibrosis. [D] . Liang, Lloyd. 2018

机译：特发性肺纤维化患者使用Gadofosveset增强肺磁共振成像测得的血管渗漏与纤维化的放射学和生理学指标的相关性。
6. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis [O] . Brett Ley, Jeffrey Swigris, Bann-mo Day, -1

机译：吡非尼酮可减少特发性肺纤维化中与呼吸有关的住院
7. Reduction in Non-Elective Respiratory-Related Hospitalizations in Patients Treated With Pirfenidone: Pooled Analyses From Three Phase 3 Trials of Pirfenidone in Idiopathic Pulmonary Fibrosis [O] . 2016

机译：用Pirfenidone治疗的患者减少非选择性呼吸学相关住院治疗：合并分析的分析术语特发性肺纤维化的三阶段3阶段试验

REDUCTION IN NON-ELECTIVE RESPIRATORY-RELATED HOSPITALIZATIONS IN PATIENTS TREATED WITH PIRFENIDONE: POOLED ANALYSES FROM THREE PHASE 3 TRIALS OF PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS

著录项

相似文献

相关主题

期刊订阅